Study of GB-0895 in patients with asthma
Latest Information Update: 15 Jan 2025
At a glance
- Drugs GB 0895 (Primary)
- Indications Asthma
- Focus Adverse reactions
Most Recent Events
- 09 Jan 2025 Status changed to completed, according to a Generate Biomedicines media release.
- 04 Jan 2024 According to a Generate Biomedicines Media Release, company will present updates from GB-0895 program, at the 42nd Annual J.P. Morgan Healthcare Conference, which will be occurring from January 8-11 in San Francisco. The presentation will take place on Jan 10 from 10:00-10:25am PST at the Golden Gate (32nd Floor) of The Westin St. Francis.
- 04 Jan 2024 Status changed to recruiting, according to a Generate Biomedicines Media Release